目的 研究誘導(dǎo)型一氧化氮合酶(iNOS)和p53蛋白在肝細胞癌中的表達及其與腫瘤血管形成的關(guān)系。
方法 采用免疫組化和圖像分析技術(shù)檢測59例肝細胞癌患者腫瘤組織中iNOS和p53蛋白的表達,CD34單克隆抗體免疫組化染色檢測腫瘤組織微血管密度(MVD)。
結(jié)果 ①iNOS和p53蛋白在肝細胞癌組織中表達陽性率分別為81.4%(48/59)和64.4%(38/59),表達強度(IOD值)分別為5 635±1 287和3 352±873。②MVD為32.5±2.73,以腫瘤邊緣和癌旁組織微血管較密集。③iNOS的表達與p53蛋白表達呈顯著正相關(guān)(r=0.65, P<0.05); iNOS的表達與MVD呈顯著正相關(guān)(r=0.75, P<0.05); p53蛋白的表達與MVD呈顯著正相關(guān)(r=0.72, P<0.05)。
結(jié)論 肝細胞癌組織中存在iNOS和p53蛋白的高表達; iNOS和p53可促進肝癌血管形成。
引用本文: 張劍,何生,李茂德. 肝細胞癌中iNOS和p53蛋白的表達及其與腫瘤血管形成的關(guān)系. 中國普外基礎(chǔ)與臨床雜志, 2004, 11(5): 396-398. doi: 復(fù)制
1. | Papapetropoulos A, GarciaCardena G, Madri JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells [J]. J Clin Invest, 1997; 100(12)∶3131. |
2. | Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wildtype p53 and vSrc exert opposing influences on human vascular endothelial growth factor gene expression [J]. Cancer Res, 1995; 55(24)∶6161. |
3. | Mattern J, Koomagi R, Volm M. Biological characterization of subgroups of squamous cell lung carcinomas [J]. Clin Cancer Res, 1999; 5(6)∶1459. |
4. | Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875. |
5. | Rosbe KW, Prazma J, Petrusz P, et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck [J]. Otolaryngol Head Neck Surg, 1995; 113(5)∶541. |
6. | Thomsen LL, Lawton FG, Knowles RG, et al. Nitric oxide synthase activity in human gynecological cancer [J]. Cancer Res, 1994; 54(5)∶1352. |
7. | Fujimoto H, Ando Y, Yamashita T, et al. Nitric oxide synthase activity in human lung cancer [J]. Jpn J Cancer Res, 1997; 88(12)∶1190. |
8. | Parenti A, Morbidelli L, Cui XL, et al. Nitric oxide is an upstream signal of vascular endothelial growth factorinduced extracellular signalregulated kinase1/2 activation in postcapillary endothelium [J]. J Biol Chem, 1998; 273(7)∶4220. |
9. | Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells [J]. Oncogene, 1997; 15(4)∶437. |
- 1. Papapetropoulos A, GarciaCardena G, Madri JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells [J]. J Clin Invest, 1997; 100(12)∶3131.
- 2. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wildtype p53 and vSrc exert opposing influences on human vascular endothelial growth factor gene expression [J]. Cancer Res, 1995; 55(24)∶6161.
- 3. Mattern J, Koomagi R, Volm M. Biological characterization of subgroups of squamous cell lung carcinomas [J]. Clin Cancer Res, 1999; 5(6)∶1459.
- 4. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875.
- 5. Rosbe KW, Prazma J, Petrusz P, et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck [J]. Otolaryngol Head Neck Surg, 1995; 113(5)∶541.
- 6. Thomsen LL, Lawton FG, Knowles RG, et al. Nitric oxide synthase activity in human gynecological cancer [J]. Cancer Res, 1994; 54(5)∶1352.
- 7. Fujimoto H, Ando Y, Yamashita T, et al. Nitric oxide synthase activity in human lung cancer [J]. Jpn J Cancer Res, 1997; 88(12)∶1190.
- 8. Parenti A, Morbidelli L, Cui XL, et al. Nitric oxide is an upstream signal of vascular endothelial growth factorinduced extracellular signalregulated kinase1/2 activation in postcapillary endothelium [J]. J Biol Chem, 1998; 273(7)∶4220.
- 9. Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells [J]. Oncogene, 1997; 15(4)∶437.